Paid Clinical Trials Buffalo

Discover 336 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 336

Bright Light TherapyEffects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors

Recruiting

Sponsor:

State University of New York at Buffalo

Location:

Buffalo NY

Code:

NCT02954809

Conditions

Fatigue

Sleep Disturbance

Circadian Dysregulation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Morning bright light therapy

Dim light

BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Recruiting

PHASE2

PHASE3

Sponsor:

Blueprint Medicines Corporation

Location:

Buffalo NY, Ann Arbor MI, New York NY, Cincinnati OHshow 6 more

Code:

NCT04910685

Conditions

Indolent Systemic Mastocytosis

Monoclonal Mast Cell Activation Syndrome

Smoldering Systemic Mastocytosis

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Elenestinib

Placebo

EVAR vs. ESARComparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

Recruiting

Sponsor:

Rijnstate Hospital

Location:

Washington AR, Buffalo NY, Royal Oak MI, Toledo OHshow 10 more

Code:

NCT05484115

Conditions

Aortic Aneurysm, Abdominal

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft system

endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchor system

VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Recruiting

Sponsor:

Bayer

Location:

Multiple Locations, Buffalo NY, Youngstown OH, Pittsburgh PAshow 42 more

Code:

NCT04142437

Conditions

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

larotrectinib(Vitrakvi, BAY2757556)

IDE196 & CrizotinibIDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting

PHASE2

PHASE3

Sponsor:

IDEAYA Biosciences

Location:

Buffalo NY, Toronto, Cleveland OH, Pittsburg PAshow 25 more

Code:

NCT05987332

Conditions

Metastatic Uveal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IDE196

Crizotinib

Pembrolizumab

Ipilimumab

Nivolumab

Tinengotinib vs. Physician's ChoiceStudy of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

Recruiting

PHASE3

Sponsor:

TransThera Sciences (Nanjing), Inc.

Location:

Buffalo NY, Cleveland OH, Detroit MI, Ann Arbor MIshow 13 more

Code:

NCT05948475

Conditions

Cholangiocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tinengotinib 8 mg

Tinengotinib 10 mg

Physician's Choice

M3814 with RadiotherapyTesting the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Buffalo NY, Pittsburgh PA, Detroit MI, Farmington Hills MIshow 32 more

Code:

NCT04172532

Conditions

Locally Advanced Pancreatic Adenocarcinoma

Stage III Pancreatic Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging

DupilumabEfficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Buffalo NY, Hamilton, Cleveland OH, Hawthorne NYshow 14 more

Code:

NCT06191315

Conditions

Wheezing

Asthma

Eligibility Criteria

Sex: All

Age: 2 - 5

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Placebo

BirtamimabA Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis

Recruiting

PHASE3

Sponsor:

Prothena Biosciences Ltd.

Location:

Buffalo NY, Cleveland OH, Detroit MI, Ann Arbor MIshow 23 more

Code:

NCT04973137

Conditions

Light Chain (AL) Amyloidosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Birtamimab

Placebo

Standard of Care Chemotherapy

GORE® EXCLUDER®Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

Recruiting

Sponsor:

W.L.Gore & Associates

Location:

Buffalo NY, Bay City MI, Grand Rapids MI, Indianapolis INshow 8 more

Code:

NCT06218875

Conditions

AAA - Abdominal Aortic Aneurysm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted